NEUP NEUP
Company Profile ↓Company Overview
NEUP (NEUP) is a publicly traded company listed on with a market capitalization of $784.91M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Growth & Price Performance
Stock Price Performance
| 1 Year: | -49.23% |
| 6 Months: | -1.86% |
| 3 Months: | -26.78% |
| 1 Month: | +10.03% |
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)53.50 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
No notable strengths flagged.
CONS
- Trading 80.2% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Sep 2023 | Dec 2023 | Mar 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | 662.72K | 15.00M | 0 | 0 | 0 |
| Cost of Revenue | - | - | - | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - | - | - | - |
| Operating Expenses | - | - | - | - | 4.06M | 3.03M | 5.65M | 2.35M | 827.28K |
| Operating Income | -5.47M | -4.55M | -2.39M | -3.57M | -3.40M | 11.97M | -5.65M | -2.35M | -827.28K |
| EBITDA | - | - | - | - | -3.23M | 12.14M | -5.49M | -2.18M | -661.59K |
| Interest Expense | - | - | - | - | - | - | - | - | - |
| Pretax Income | - | - | - | - | -1.93M | 11.18M | -9.94M | 1.83M | -539.86K |
| Tax Provision | - | - | - | - | 11.61K | -81.19K | -34.79K | -34.79K | -34.79K |
| Net Income | -5.47M | -4.55M | -2.78M | -804.79K | -1.94M | 11.26M | -9.91M | 1.86M | -505.06K |
| Diluted EPS | 0.00 | -5.31 | -2.83 | -0.62 | -1.79 | 6.55 | -4.41 | -0.77 | -0.09 |
| R&D Expense | 3.09M | 2.03M | 1.20M | 1.90M | 1.74M | 1.62M | 3.79M | 697.72K | - |
Profit & Loss (Annual)
Figures in USD.
| Metric | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 |
|---|---|---|---|---|
| Revenue | 181.36K | 0 | 0 | - |
| Cost of Revenue | - | - | - | - |
| Gross Profit | - | - | - | - |
| Operating Expenses | 14.86M | 21.56M | 17.80M | - |
| Operating Income | -14.68M | -21.56M | -17.80M | - |
| EBITDA | -14.32M | -20.90M | -17.13M | - |
| Interest Expense | 18.49K | 14.08K | - | - |
| Pretax Income | -15.10M | -21.52M | -15.58M | - |
| Tax Provision | -131.95K | -139.17K | -87.32K | - |
| Net Income | -14.97M | -21.38M | -15.49M | - |
| Diluted EPS | -0.17 | -0.16 | -0.12 | -0.23 |
| R&D Expense | - | 13.07M | 9.42M | 9.01M |
Balance Sheet (Annual)
Figures in USD.
| Metric | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 |
|---|---|---|---|---|
| Total Assets | 44.93M | 28.56M | 27.65M | 28.59M |
| Current Assets | 28.76M | 13.33M | 13.19M | - |
| Cash & Equivalents | 23.09M | 12.10M | 12.61M | 14.21M |
| Inventory | - | - | - | - |
| Receivables | 4.67M | 426.09K | 126.88K | - |
| Total Liabilities | 5.78M | 6.55M | 10.16M | 9.59M |
| Current Liabilities | 2.31M | 2.74M | 3.83M | 4.22M |
| Long Term Debt | - | - | - | - |
| Total Debt | 477.15K | 386.92K | 272.74K | - |
| Total Equity | 39.15M | 22.01M | 17.49M | 19.00M |
| Shares Outstanding | 1.35B | 1.47B | 198.71M | - |
Cash Flows (Annual)
Figures in USD.
| Metric | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 |
|---|---|---|---|---|
| Operating Cash Flow | -14.97M | -14.64M | -14.68M | 77.23K |
| Investing Cash Flow | 427.68K | 317.41K | - | - |
| Financing Cash Flow | 18.57M | 3.86M | 15.11M | 1.53M |
| Capital Expenditure | -1.06K | - | - | - |
| Free Cash Flow | -14.97M | -14.64M | -14.68M | - |
| Net Change in Cash | 4.03M | -10.78M | 428.02K | - |
Ratios (Annual)
Figures in %.
| Metric | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 |
|---|---|---|---|---|
| Gross Margin % | - | - | - | - |
| Operating Margin % | -8,095.1% | - | - | - |
| Net Margin % | -8,253.6% | - | - | - |
| ROE % | -38.2% | -97.1% | -88.6% | - |
| ROCE % | -34.4% | -83.5% | -74.7% | - |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for NEUP
NEUP Stock Alert: Halper Sadeh LLC is Investigating Whether Neuphoria Therapeutics Inc. is Obtaining a Fair Price for its Shareholders - Business Wire
<a href="https://news.google.com/rss/articles/CBMimgJBVV95cUxOQU90OHNLN1V1SW9WVjRHb01GY1V1N00xQjNOY2RMWUtDZ0lMbm41di1CVWpfYklzRFp2Ulo4ejliUTBSNDNzOFVNdGdhQi13ckhiWXRvTkcyMGZ0NUJ3YXpTMHUtcVZCY1pxM3YzSHdXeXRmaEw0SXJEY3VGU24wRGs0M0V6MDB3eUsxMn…
Are CBZ, SAFT, NEUP, TCBK Obtaining Fair Deals for their Shareholders? - Morningstar
<a href="https://news.google.com/rss/articles/CBMixgFBVV95cUxPR1U2MU9DWGxiVjhKdlZoZjlfSzhHWWpJdHpOQUJCLWhtTlFCcTIyZDVjOGlyb0RsLTM1UUxhTEVSWE83eEZsdnY4aDFvNTRGcDFCdlBRekZMVVk4ZGhKNkpjR21tTE92dFhsa1dJTEFqeGRFZ2t2cV9yaWIzZnN1N2dHSE0xRGtNUDF5cE…
NEUP|Neuphoria Therapeutics Inc|Price:3.880|Chg%:-0.040 - TradingKey
<a href="https://news.google.com/rss/articles/CBMibkFVX3lxTE1sR1pJRGt3STJZMlVXV0xFaUdBUEZIU3Z2SDlRQkx5UDN3WS1KWFp2bTA2b2dRMm5JX1kwU3dnanlTNGRIRWZwc1EyZ3l0S3JFSnVXWEREYnVFLUp0VVF6ZnFOWTJRYjhTZU5qNGd3?oc=5" target="_blank">NEUP|Neuphoria Ther…
Neuphoria Therapeutics Inc (NASDAQ: NEUP) Share Price, NEUP Stock News, NEUP Share Price & Updates - Kalkine
<a href="https://news.google.com/rss/articles/CBMiVkFVX3lxTE5EeUN2cHI2MTNvZ3pNSHdlSEZiWk0yaDdEQlRJMGxwM293TUNtLUdhbHpsam9qRWVxb1hLV3NsWUE5T0tlNUYyRDVsY3EtVU9EdXo4alVR?oc=5" target="_blank">Neuphoria Therapeutics Inc (NASDAQ: NEUP) Share Pri…
Neuphoria Therapeutics (NEUP) Confirms Acquisition Talks with Sc - GuruFocus
<a href="https://news.google.com/rss/articles/CBMi7AFBVV95cUxNMzlqMHd2aktYSkJoZUxjb0xHYllXcjNjb3paQUFLNEl0ZUQwc2Q2LVotMkhFaWs3cFhKYXhma0hNbjFqQWJXMlRwSVBMSlNtM0xnR25YeHJhOXNiS1Mzc2o2aDJ3MVJtdElPUFhnZlkwejIxOFAwaXA5cXdVdXQ4bE9uVjV3RTVKWWZQZ2…
Here's Why We're A Bit Worried About Neuphoria Therapeutics' (NASDAQ:NEUP) Cash Burn Situation - simplywall.st
<a href="https://news.google.com/rss/articles/CBMi7AFBVV95cUxQR2otQ3RKTkt6VDJpOWZLTE9ZUTNjb2NOMXFCRjlkamRUWFM3Q1RHVk56VGUyQXY0Y2RPdUVfSzFTZ2R2d1FFLTVoY0RwWnppb0hjaVlSMGkzV3BoaGtRTXZGcmlRM1FwVzJWT1I0NjZFazFHZ0hyZWpuOW5NVkhiMnR4blRaX29lTm1uMV…
NEUP — Frequently Asked Questions
What is the current share price of NEUP?
As of 2026-08-05 17:25 PDT, NEUP trades at $3.95 on NASDAQ/NYSE. Its 52-week range is $3.30 to $20.00.
What is the market capitalisation of NEUP?
NEUP has a market capitalisation of $784.91M on NASDAQ/NYSE.
What is the P/E ratio of NEUP?
NEUP trades at a trailing price-to-earnings (P/E) ratio of -17.17. Its price-to-book (P/B) ratio is 41.32.
What is the return on equity (ROE) of NEUP?
NEUP has a return on equity (ROE) of -81.53%. Its return on capital employed (ROCE) is -73.03%.
Is NEUP a good stock to buy?
This page provides a data-driven analysis of NEUP, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.